Aberdeen Group plc Increases Position in ARS Pharmaceuticals, Inc. $SPRY
MarketBeat
Aberdeen Group plc raised its position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 49.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,502,575 shares of the company's stock after purchasing an addition
NASDAQ:SPRY